AU2002327562A1 - A method to determine the risk for side effects of an ssri treatment in a person - Google Patents

A method to determine the risk for side effects of an ssri treatment in a person

Info

Publication number
AU2002327562A1
AU2002327562A1 AU2002327562A AU2002327562A AU2002327562A1 AU 2002327562 A1 AU2002327562 A1 AU 2002327562A1 AU 2002327562 A AU2002327562 A AU 2002327562A AU 2002327562 A AU2002327562 A AU 2002327562A AU 2002327562 A1 AU2002327562 A1 AU 2002327562A1
Authority
AU
Australia
Prior art keywords
risk
person
side effects
ssri treatment
ssri
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002327562A
Inventor
Greer M. Murphy
Alan F. Schatzberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2002327562A1 publication Critical patent/AU2002327562A1/en
Abandoned legal-status Critical Current

Links

AU2002327562A 2001-08-29 2002-08-29 A method to determine the risk for side effects of an ssri treatment in a person Abandoned AU2002327562A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60/315,644 2001-08-29

Publications (1)

Publication Number Publication Date
AU2002327562A1 true AU2002327562A1 (en) 2003-03-18

Family

ID=

Similar Documents

Publication Publication Date Title
AU2003256253A8 (en) Aerosol for medical treatment and methods
AU2001259758A1 (en) Interleukin-1 inhibitors in the treatment of diseases
AU2003202196A1 (en) Devices and methods for heart valve treatment
AU2003268681A1 (en) Cyclic structure formation method and surface treatment method
PL374118A1 (en) Interleukin-1 receptors in the treatment of diseases
ZA200410409B (en) Use of thio-oxindole derivatives in treatment of hormonerelated conditions
AU2003232044A8 (en) Composition and method for dermatological treatment
AU2003232148A1 (en) A selective inos inhibitor and a pde inhibitor in combination for the treatment of respiratory diseases
AU2002338191A1 (en) Surface treatment system and surface treatment method
GB2383537B (en) Use of a compound in providing refreshedness on waking and a method for the treatment of drowsiness therewith
AU2002313364A1 (en) Use of a compound in providing refreshedness on waking and a method for the treatment of drowsiness therewith
EP1575993A4 (en) Methods for treating patients and identifying therapeutics
AU2002352566A1 (en) Use of corrinoids in the treatment of skin diseases
AU2002359074A1 (en) Surface treatment system and method
AU2003218834A1 (en) Methods for the treatment and prevention of overweight in mammals
AU2002322792A1 (en) Method and apparatus for providing complex tissue stimulation patterns
GB0210741D0 (en) Methods of therapy
AU2002359061A1 (en) Surface treatment system and method thereof
AU2002258922A1 (en) Method for assessing risk for cardiac dysrhythmia in a human subject
EP1450831A4 (en) Methods of treatment in situ in the lungs of mammals
EP1435970A4 (en) Methods of treating skin with diphosphonate derivatives
AU2002327562A1 (en) A method to determine the risk for side effects of an ssri treatment in a person
EP1679075A4 (en) Transdermal preparations and method for relieving side effects in pergolide therapy
GB0023599D0 (en) Non-invasive method for determining human photodermatoogical skin-types
EP1411354A4 (en) Method of detecting skin stimulation effect